Your browser doesn't support javascript.
COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies.
Declercq, Jozefien; Tobback, Els; Vanhee, Stijn; De Ruyck, Natalie; Gerlo, Sarah; Gevaert, Philippe; Vandekerckhove, Linos.
  • Declercq J; Upper Airways Research Lab URL, Department of Otorhinolaryngology, Ghent University, Ghent, Belgium.
  • Tobback E; Laboratory of immunoregulation and mucosal immunology, VIB Center for Inflammation Research, Ghent, Belgium.
  • Vanhee S; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
  • De Ruyck N; Department of General Internal Medicine, Ghent University Hospital, Ghent, Belgium.
  • Gerlo S; Laboratory of immunoregulation and mucosal immunology, VIB Center for Inflammation Research, Ghent, Belgium.
  • Gevaert P; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
  • Vandekerckhove L; Upper Airways Research Lab URL, Department of Otorhinolaryngology, Ghent University, Ghent, Belgium.
Allergy ; 77(1): 304-307, 2022 01.
Article in English | MEDLINE | ID: covidwho-1429478
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Allergy Year: 2022 Document Type: Article Affiliation country: All.15101

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Allergy Year: 2022 Document Type: Article Affiliation country: All.15101